Financials • Investment Managers
$120.60 ▲ +3.54
(+3.02%)
MKT CAP: $90.53B • VOL: 4.16M
52W L $102 52W H $165
BX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $14.45B | $13.23B | $8.02B |
| YoY Revenue Growth % | +9.2% | +64.9% | — |
| Gross Profit | $6.36B | $5.82B | $3.53B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.56B | $3.28B | $1.64B |
| Operating Margin % | 24.7% | 24.8% | 20.5% |
| Net Income (GAAP) | $3.02B | $2.78B | $1.39B |
| EBITDA (Normalized) | $3.66B | $3.33B | $1.93B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.66B | $3.48B | $4.06B |
| Capital Expenditures (CapEx) | $115.7M | $61.4M | $361.0M |
| Free Cash Flow (FCF) | $4.55B | $3.42B | $3.70B |
| FCF Margin % | 31.5% | 25.9% | 46.1% |
| Return on Invested Capital (ROIC %) | 15.9% | 15.2% | 4.3% |
| Cash & Short-Term Equivalents | $2.63B | $1.97B | $5.48B |
| Total Debt (Short + Long Term) | $11.62B | $10.79B | $11.65B |
| Total Stockholders' Equity | $8.67B | $8.21B | $23.90B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BX.